Qualitative Study: Gathering patient perspectives on inducing immune tolerance with regulatory T cell therapy

Are you or a solid organ transplant or stem cell recipient? Have you or may soon require a blood stem cell transplant for a blood cancer?

Dr. Megan Levings from the University of British Columbia invites you to share your valuable perspectives on receiving Regulatory T cells (Tregs) therapy. As a patient partner, here is what you can expect:

  • Ideally, you will attend a background presentation about the research project. During this presentation, you will have the opportunity to ask questions and comments (1 hour commitment). The presentation will be held on Tuesday, January 30, 2024, from 6:00 – 7:00 pm EST.
  • After the presentation, you will receive a survey to complete (1 hour commitment)
  • If you consent to further contact, following the survey and analysis of themes, the research team may invite you to participate in a group discussion to discuss results and provide you with an opportunity to clarify or expand on these results (1 hour).
Learn more
If you are interested, connect with CDTRP’s Patient, Family, and Donor Partnership Manager, Manuel, at mescoto@cdtrp.ca.